M3 stock trades 32.6 percent below its 52-week high

M3 stock (ISIN JP3435750009) stood 32.6 percent below its 52-week high of JPY 2,746 on October 8, 2026, while its market capitalization reached JPY 1.2 trillion. The Tokyo-listed healthcare information services company had fiscal Q1 revenue of JPY 90.11 billion and net profit of JPY 9.07 billion, according to Markets Insider.

Revenue grows as profit falls

The quarter ended June 30, 2026, produced revenue of JPY 90.11 billion, up from JPY 86.2 billion a year earlier. That is a 4.5 percent increase, but net profit declined from JPY 11.84 billion to JPY 9.07 billion, a 23.4 percent decrease, according to Markets Insider.

Yahoo Finance lists the fiscal Q1 profit margin at 10.07 percent. For investors, the contrast between 4.5 percent revenue growth and the 23.4 percent profit decline makes operating efficiency more important than headline sales growth.

Morgan Stanley keeps Hold rating

Morgan Stanley maintained a Hold rating on October 2, 2026, and set a JPY 2,100 price target, as reported by Markets Insider. The same report described a broader Hold consensus with an average price target of JPY 2,008.84, although it did not publish a covering-analyst count or a high and low target.

The analyst view leaves M3 between an earnings recovery question and a governance debate. A higher revenue base supports the platform model, while the lower quarterly profit shows why investors may place greater weight on margins and capital allocation in the next results cycle.

Tokyo listing stays below yearly high

Global Banking & Finance Review identifies M3 as ticker 2413.T on the Tokyo Stock Exchange and assigns ISIN JP3435750009 to the listing. The 52-week range extends from JPY 1,297 to JPY 2,746, leaving the October 8 level 32.6 percent below the upper end.

M3 was last at JPY 1,851.50 on the Tokyo Stock Exchange on October 8, 2026, at 3:30 p.m. JST, up 0.33 percent, with volume of 2,864,900 shares.

More news and analyses on M3 stock